EGFR-IN-7 |
Catalog No.GC35966 |
L'EGFR-IN-7 est un inhibiteur de l'EGFR kinase puissant, sélectif et actif par voie orale. EGFR-IN-7 a un effet inhibiteur pour EGFR (WT) et EGFR (mutant C797S/T790M/L858R) avec des valeurs IC50 de 7,92 nM et 0,218 nM, respectivement. EGFR-IN-7 montre une activité anti-tumorale. EGFR-IN-7 peut être utilisé pour la recherche de divers cancers.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2267329-76-8
Sample solution is provided at 25 µL, 10mM.
EGFR-IN-7 (compound 34) is a selective and potent EGFR kinase inhibitor extracted from patent WO2019015655A1, has IC50s of 7.92 nM and 0.218 nM for EGFR (WT) and EGFR (mutant C797S/T790M/L858R) respectively, and shows anti-tumor activity[1]. EGFR (WT)|7.92 nM (IC50)|EGFR (C797S/T790M/L858R)|0.218 nM (IC50)
[1]. Aryl-phosphorus-oxygen compound as egfr kinase inhibitor.
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *